IDEXX Laboratories, a Nasdaq-listed pet healthcare company, has announced the launch of IDEXX Cancer Dx, a diagnostic panel for early detection of lymphoma in dogs.
The panel will be available in the US and Canada through IDEXX Reference Laboratories starting in late March 2025.
Priced from $15, IDEXX Cancer Dx can be incorporated into routine wellness screenings or diagnostic panels for sick pets, with results delivered within two to three days. IDEXX plans to expand the panel over the next three years to cover additional canine cancers, enhancing early detection and intervention capabilities.
According to IDEXX Laboratories, the panel delivers high diagnostic accuracy, with 74% sensitivity and 99% specificity rates.
IDEXX Laboratories president and CEO Jay Mazelsky said: “Building on over 40 years of IDEXX’s leadership in veterinary research and technology development, IDEXX Cancer Dx is our latest groundbreaking solution to deliver unmatched diagnostic insights.
“As leaders in key cancer diagnostic categories, like pathology and imaging, we continue to innovate technologies that can redefine how veterinarians approach cancer detection and monitoring in pets.
“We’re proud to be at the forefront of early cancer detection in dogs and look forward to expanding IDEXX Cancer Dx to cover other cancer types.”
Veterinarians can add IDEXX Cancer Dx to existing workflows using a single blood sample. Results are expected to be supported by IDEXX Medical Consultants, including board-certified oncologists, and are accompanied by client education materials for effective communication with pet owners.
The initial rollout focuses on lymphoma detection, providing qualitative results and B-cell and T-cell phenotype classifications at no extra cost.
IDEXX Laboratories plans to extend its capabilities to detect more common canine cancers in the future, broadening its impact on preventive care and treatment outcomes.
As part of the IDEXX Preventive Care portfolio, the Cancer Dx panel aims to provide actionable insights for at-risk dogs while integrating seamlessly into veterinary practices.
